Ultragenyx Experiences $1 Billion Drop in Market Value After Bone Treatment's Inability to Lower Fracture Rates

Ultragenyx Experiences $1 Billion Drop in Market Value After Bone Treatment’s Inability to Lower Fracture Rates

Ultragenyx Experiences $1 Billion Drop in Market Value After Bone Treatment's Inability to Lower Fracture Rates